OOIR: Observatory of International Research

Papers

(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Use of serum MKRN3 and DLK1 levels in precocious puberty: association with an MKRN3 pathogenic variant	317
The type 2 deiodinase Thr92Ala polymorphism and cognitive aging: current evidence and biological context	213
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review	65
Controversies in the management of active Charcot neuroarthropathy	54
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach	36
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review	33
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults	33
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses	29
Leave no bone unturned: metabolic bone disease in special populations	26
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system	25
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor	22
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study	22
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers	22
Is there a causal relationship between hypothyroidism and hyponatremia?	22
Antidiabetic drug and chronic respiratory disease in type 2 diabetes: a network meta-analysis and Mendelian randomization analysis	21
Pheochromocytoma: a changing perspective and current concepts	20
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes	19
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates	19
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus	18
Using digital tools to improve diabetes care in India with continuous glucose monitoring	18
Determination of the relationship between raftlin, oxidative stress levels, and vitamin D receptor gene polymorphism in diabetic patients	18